Evoke Pharma Inc. (EVOK)
2.82
0.00 (0.00%)
At close: Mar 24, 2025, 3:37 PM
2.85
1.08%
After-hours: Mar 24, 2025, 04:09 PM EDT
Evoke Pharma Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Revenue | 10,249.4B | 5.18M | 2.51M | 1.62M | 23.02K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | 201.88K | 370.39K | 328.12K | 86.71K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | 10,249.4B | 4.98M | 2.14M | 1.29M | -63.69K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Income | -5,204.1B | -7.43M | -7.79M | -8.15M | -13.05M | -7.15M | -8.01M | -11.23M | -10.54M | -11.82M | -13.15M | -2.6M | -2M | -2.41M |
| Interest Income | 353.31B | 138.6K | 62.01K | 8.62K | 5.67K | 28.8K | 15.21K | n/a | n/a | n/a | 10.19K | 7.25K | 1.69K | 10.7K |
| Pretax Income | -5,352.2B | -7.79M | -8.22M | -8.54M | -13.15M | -7.13M | -7.57M | -12.23M | -10.75M | -12.12M | -13.25M | -2.84M | -2.02M | -2.4M |
| Net Income | -5,352.2B | -7.79M | -8.16M | -9.03M | -13.26M | -7.1M | -7.57M | -12.23M | -10.75M | -12.12M | -13.25M | -2.84M | -2.02M | -2.4M |
| Selling & General & Admin | 15,080.7B | 12.23M | 9.62M | 8.85M | 6.43M | 3.74M | 3.92M | 4.09M | 3.59M | 3.66M | 3.16M | 1.64M | 836.78K | 570.52K |
| Research & Development | 16.32B | 181.91K | 300.79K | 590.48K | 6.55M | 3.42M | 4.1M | 7.14M | 6.95M | 8.15M | 9.99M | 956.98K | 1.17M | 1.84M |
| Other Expenses | 356.53B | n/a | 370.39K | 328.12K | 86.71K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 15,453.6B | 12.41M | 9.92M | 9.44M | 12.98M | 7.15M | 8.01M | 11.23M | 10.54M | 11.82M | 13.15M | 2.6M | 2M | 2.41M |
| Interest Expense | -501.37B | 500K | 500K | 500.05K | 112.99K | n/a | 15.21K | 6.52K | 268.03K | n/a | 107.83K | 159.88K | 24.04K | 2.87K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 15,453.6B | 12.61M | 10.29M | 9.77M | 13.07M | 7.15M | 8.01M | 11.23M | 10.54M | 11.82M | 13.15M | 2.6M | 2M | 2.41M |
| Income Tax | n/a | n/a | -62.01K | 491.44K | 107.32K | -28.8K | -912.42K | -6.52K | 801.72K | n/a | n/a | 152.64K | 22.35K | -7.82K |
| Shares Outstanding (Basic) | 1.4M | 278.59K | 261.97K | 223.51K | 177.03K | 154.83K | 115.29K | 103.46K | 64.85K | 45.04K | 41.89K | 16.44K | 8.61K | 7.9K |
| Shares Outstanding (Diluted) | 1.4M | 278.59K | 261.97K | 223.51K | 177.03K | 154.83K | 115.29K | 103.46K | 64.85K | 45.04K | 41.89K | 16.44K | 8.61K | 7.9K |
| EPS (Basic) | -3.82M | -27.97 | -31.16 | -40.4 | -74.91 | -45.84 | -65.62 | -118.21 | -165.75 | -269.13 | -316.23 | -172.49 | -234.27 | -304.11 |
| EPS (Diluted) | -3.82M | -27.97 | -31.16 | -40.4 | -74.91 | -45.84 | -65.62 | -118.21 | -165.75 | -269.13 | -316.23 | -172.49 | -234.27 | -304.11 |
| EBITDA | -5,204.1B | -7.29M | -7.72M | -8.04M | -13.04M | n/a | n/a | n/a | n/a | -11.52M | -13.14M | -2.59M | -1.99M | -2.4M |
| Depreciation & Amortization | n/a | 138.6K | 7.79M | 8.15M | 13.05M | 7.15M | 8.01M | 11.23M | 10.54M | 303.16K | 10.19K | 7.25K | 1.69K | 10.7K |